Letter: Bacteroides infections.
D001439:Bacteroides / Q000302:isolation & purification; D001442:Bacteroides Infections / Q000188:drug therapy / Q000382:microbiology*; D002981:Clindamycin / Q000627:therapeutic use; D003470:Culture Media; D004341:Drug Evaluation; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D006801:Humans; D007410:Intestinal Diseases / Q000601:surgery; D008034:Lincomycin / Q000627:therapeutic use; D008795:Metronidazole / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D013530:Surgical Wound Infection / Q000382:microbiology; D013752:Tetracycline / Q000627:therapeutic use
D003470:Culture Media; D008795:Metronidazole; D002981:Clindamycin; D008034:Lincomycin; D013752:Tetracycline; D012293:Rifampin